<VariationArchive VariationID="2424349" VariationName="NC_000008.10:g.(?_11565822)_(11566457_?)del" VariationType="Deletion" Accession="VCV002424349" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1939509" VariationID="2424349">
      <GeneList>
        <Gene Symbol="GATA4" FullName="GATA binding protein 4" GeneID="2626" HGNC_ID="HGNC:4173" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="11676935" stop="11760002" display_start="11676935" display_stop="11760002" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NW_018654717.1" start="1588081" stop="1671134" display_start="1588081" display_stop="1671134" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="11561716" stop="11617508" display_start="11561716" display_stop="11617508" Strand="+" />
          </Location>
          <OMIM>600576</OMIM>
          <Haploinsufficiency last_evaluated="2017-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GATA4">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GATA4">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000008.10:g.(?_11565822)_(11566457_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8p23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" innerStart="11565822" innerStop="11566457" display_start="11565822" display_stop="11566457" variantLength="636" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.(?_11565822)_(11566457_?)del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.(?_11565822)_(11566457_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000008.10:g.(?_11565822)_(11566457_?)del AND Atrioventricular septal defect 4" Accession="RCV003107582" Version="4">
        <ClassifiedConditionList TraitSetID="7862">
          <ClassifiedCondition DB="MedGen" ID="C3280781">Atrioventricular septal defect 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12845333</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15235040</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7862" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16793" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Atrioventricular septal defect 4</ElementValue>
                <XRef ID="MONDO:0013747" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AVSD4</ElementValue>
                <XRef Type="MIM" ID="614430" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The term 'atrioventricular septal defect' (AVSD) covers a spectrum of congenital heart malformations characterized by a common atrioventricular junction coexisting with deficient atrioventricular septation. In ostium primum atrial septal defect (ASD) there are separate atrioventricular valvar orifices despite a common junction, whereas in complete AVSD the valve itself is also shared (summary by Craig, 2006).
AVSD, also designated endocardial cushion defect or atrioventricular canal defect (AVCD), is known to occur in either a nonsyndromic (isolated) form or, more commonly, as part of a malformation syndrome. The 2 syndromes most frequently associated with AVSD are Down syndrome (190685), in which AVSD is the most frequent congenital heart defect, and Ivemark syndrome (208530) (summary by Carmi et al., 1992).
For a discussion of genetic heterogeneity of atrioventricular septal defects, see AVSD1 (606215).</Attribute>
                <XRef Type="MIM" ID="614430" DB="OMIM" />
              </AttributeSet>
              <XRef ID="C3280781" DB="MedGen" />
              <XRef ID="MONDO:0013747" DB="MONDO" />
              <XRef Type="MIM" ID="614430" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7073194" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_002052.3_8_Deletion (exon 2)|MedGen:C3280781" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003794570" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12845333</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15235040</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 2 of the GATA4 gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GATA4 are known to be pathogenic (PMID: 12845333, 15235040). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with GATA4-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GATA4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.(?_11565822)_(11566457_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280781" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7073194" TraitType="Disease" MappingType="XRef" MappingValue="C3280781" MappingRef="MedGen">
        <MedGen CUI="C3280781" Name="Atrioventricular septal defect 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

